Research Project
Project Title: |
Phase 3 study to evaluate the efficacy and safety of LNP023 on proteinuria and renal function decline in primary IgA nephropathy patients |
Project Type: |
Clinical Trial, Enrolment ongoing |
Disease group(s): |
Immune glomerulopathies |
Project Summary: |
Phase 3 study to evaluate the efficacy and safety of LNP023 on proteinuria and renal function decline in primary IgA nephropathy patients |
Lead principal investigator(s): |
Gaetano La Manna, Bologna |
Co-investigator(s): |
Beatrice Claudia Marchegiani, Bologna Serena Speciale, Bologna Olga Baraldi, Bologna Gisella Vischini, Bologna |
Project Period: |
11/2021 - 12/2025 |
Sponsors: |
Industry |
« Back to research page